• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Equimatrix is Here!!!

Anonymous

Guest
South Korean horse bone has hit the market. Why would ANYONE buy this shit? OHD's marketing strategy is to call it "like Bio-Oss", the same thing they bashed ACE for doing all these years.